Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1995 Feb;50(2):139–142. doi: 10.1136/thx.50.2.139

Effects of fenoterol on ventilatory responses to hypoxia and hypercapnia in normal subjects.

Y Yoshiike 1, S Suzuki 1, Y Watanuki 1, T Okubo 1
PMCID: PMC473901  PMID: 7701451

Abstract

BACKGROUND--The effects of beta 2 adrenergic agonists on chemoreceptors remain controversial. This study was designed to examine whether fenoterol, a beta 2 adrenergic agonist, increases the ventilatory responses to hypercapnia (HCVR) and hypoxia (HVR) in normal subjects. METHODS--HCVR was tested with a rebreathing method and HVR was examined with a progressive isocapnic hypoxic method in 11 normal subjects. Both HCVR and HVR were assessed by the slope of occlusion pressure (P0.1) or ventilation (VE) plotted against end tidal carbon dioxide pressure and arterial oxygen saturation, respectively. Respiratory muscle strength, spirometric values and lung volume were measured. After a single oral administration of 5 mg fenoterol or placebo HCVR and HVR were evaluated. RESULTS--Fenoterol treatment did not change the specific airway conductance or forced expiratory volume in one second. Respiratory muscle strength did not change. Fenoterol increased the slope of the HCVR of both P0.1 (from 0.251 (0.116) to 0.386 (0.206) kPa/kPa, average increase 71%) and VE (from 10.7 (3.4) to 15.1 (4.2) l/min/kPa, average increase 52%), and shifted the response curves to higher values. For the HVR fenoterol increased the slopes of both P0.1 and VE (from -4.06 (2.00) x 10(-3) to -7.99 (4.29) x 10(-3) kPa/%, an average increase of 83%, and from -0.221 (0.070) to -0.313 (0.112) l/min/%, a 44.5% increase, respectively), and shifted the response curves to higher values. CONCLUSION--Acute administration of fenoterol increases the ventilatory responses to both hypercapnia and hypoxia in normal subjects.

Full text

PDF
139

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amoroso P., Wilson S. R., Moxham J., Ponte J. Acute effects of inhaled salbutamol on the metabolic rate of normal subjects. Thorax. 1993 Sep;48(9):882–885. doi: 10.1136/thx.48.9.882. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Black L. F., Hyatt R. E. Maximal respiratory pressures: normal values and relationship to age and sex. Am Rev Respir Dis. 1969 May;99(5):696–702. doi: 10.1164/arrd.1969.99.5.696. [DOI] [PubMed] [Google Scholar]
  3. CHERNIACK R. M., SNIDAL D. P. The effect of obstruction to breathing on the ventilatory response to CO2. J Clin Invest. 1956 Nov;35(11):1286–1290. doi: 10.1172/JCI103383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chapman K. R., Smith D. L., Rebuck A. S., Leenen F. H. Hemodynamic effects of inhaled ipratropium bromide, alone and combined with an inhaled beta 2-agonist. Am Rev Respir Dis. 1985 Oct;132(4):845–847. doi: 10.1164/arrd.1985.132.4.845. [DOI] [PubMed] [Google Scholar]
  5. DeWeese E. L., Sullivan T. Y., Yu P. L. Neuromuscular response to resistive unloading: helium vs. bronchodilation. J Appl Physiol Respir Environ Exerc Physiol. 1984 May;56(5):1308–1313. doi: 10.1152/jappl.1984.56.5.1308. [DOI] [PubMed] [Google Scholar]
  6. Eldridge F. L., Gill-Kumar P. Mechanisms of hyperpnea induced by isoproterenol. Respir Physiol. 1980 Jun;40(3):349–363. doi: 10.1016/0034-5687(80)90034-1. [DOI] [PubMed] [Google Scholar]
  7. Eldridge F. L., Vaughn K. Z. Relationship of thoracic volume and airway occlusion pressure: muscular effects. J Appl Physiol Respir Environ Exerc Physiol. 1977 Aug;43(2):312–321. doi: 10.1152/jappl.1977.43.2.312. [DOI] [PubMed] [Google Scholar]
  8. Engel L. A., Ritchie B. Ventilatory response to inhaled carbon dioxide in hyperthyroidism. J Appl Physiol. 1971 Feb;30(2):173–177. doi: 10.1152/jappl.1971.30.2.173. [DOI] [PubMed] [Google Scholar]
  9. Folgering H. Central beta-adrenergic effects on the control of ventilation in cats. Respiration. 1980;39(3):131–138. doi: 10.1159/000194207. [DOI] [PubMed] [Google Scholar]
  10. Gelfand R., Lambertsen C. J. Dynamic respiratory response to abrupt change of inspired CO2 at normal and high PO2. J Appl Physiol. 1973 Dec;35(6):903–913. doi: 10.1152/jappl.1973.35.6.903. [DOI] [PubMed] [Google Scholar]
  11. Giles R. E., Williams J. C., Finkel M. P. The bronchodilator and cardiac stimulant effects of Thll65a, salbutamol and isoproterenol. J Pharmacol Exp Ther. 1973 Sep;186(3):472–481. [PubMed] [Google Scholar]
  12. Grogaard J., Sundell H. Effect of beta-adrenergic agonists on apnea reflexes in newborn lambs. Pediatr Res. 1983 Mar;17(3):213–219. doi: 10.1203/00006450-198303000-00010. [DOI] [PubMed] [Google Scholar]
  13. Heistad D. D., Wheeler R. C., Mark A. L., Schmid P. G., Abboud F. M. Effects of adrenergic stimulation on ventilation in man. J Clin Invest. 1972 Jun;51(6):1469–1475. doi: 10.1172/JCI106943. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Keltz H., Samortin T., Stone D. J. Hyperventilation: a manifestation of exogenous -adrenergic stimulation. Am Rev Respir Dis. 1972 Apr;105(4):637–640. doi: 10.1164/arrd.1972.105.4.637. [DOI] [PubMed] [Google Scholar]
  15. Lahiri S., Pokorski M., Davies R. O. Augmentation of carotid body chemoreceptor responses by isoproterenol in the cat. Respir Physiol. 1981 Jun;44(3):351–364. doi: 10.1016/0034-5687(81)90029-3. [DOI] [PubMed] [Google Scholar]
  16. Leitch A. G., Clancy L. J., Costello J. F., Flenley D. C. Effect of intravenous infusion of salbutamol on ventilatory response to carbon dioxide and hypoxia and on heart rate and plasma potassium in normal men. Br Med J. 1976 Feb 14;1(6006):365–367. doi: 10.1136/bmj.1.6006.365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Read D. J. A clinical method for assessing the ventilatory response to carbon dioxide. Australas Ann Med. 1967 Feb;16(1):20–32. doi: 10.1111/imj.1967.16.1.20. [DOI] [PubMed] [Google Scholar]
  18. Rebuck A. S., Campbell E. J. A clinical method for assessing the ventilatory response to hypoxia. Am Rev Respir Dis. 1974 Mar;109(3):345–350. doi: 10.1164/arrd.1974.109.3.345. [DOI] [PubMed] [Google Scholar]
  19. Rominger K. L., Pollmann W. Vergleichende Pharmakokinetik von Fenoterol-Hydrobromid bei Ratte, Hund und Mensch. Arzneimittelforschung. 1972 Jul;22(7):1190–1196. [PubMed] [Google Scholar]
  20. Suzuki S., Numata H., Sano F., Yoshiike Y., Miyashita A., Okubo T. Effects and mechanism of fenoterol on fatigued canine diaphragm. Am Rev Respir Dis. 1988 May;137(5):1048–1054. doi: 10.1164/ajrccm/137.5.1048. [DOI] [PubMed] [Google Scholar]
  21. Wasserman K., Mitchell R. A., Berger A. J., Casaburi R., Davis J. A. Mechanism of the isoproterenol hyperpnea in the cat. Respir Physiol. 1979 Dec;38(3):359–376. doi: 10.1016/0034-5687(79)90061-6. [DOI] [PubMed] [Google Scholar]
  22. Wasserman K., Whipp B. J., Castagna J. Cardiodynamic hyperpnea: hyperpnea secondary to cardiac output increase. J Appl Physiol. 1974 Apr;36(4):457–464. doi: 10.1152/jappl.1974.36.4.457. [DOI] [PubMed] [Google Scholar]
  23. Weil J. V., Byrne-Quinn E., Sodal I. E., Kline J. S., McCullough R. E., Filley G. F. Augmentation of chemosensitivity during mild exercise in normal man. J Appl Physiol. 1972 Dec;33(6):813–819. doi: 10.1152/jappl.1972.33.6.813. [DOI] [PubMed] [Google Scholar]
  24. Whitelaw W. A., Derenne J. P., Milic-Emili J. Occlusion pressure as a measure of respiratory center output in conscious man. Respir Physiol. 1975 Mar;23(2):181–199. doi: 10.1016/0034-5687(75)90059-6. [DOI] [PubMed] [Google Scholar]
  25. Winn R., Hildebrandt J. R., Hildebrandt J. Cardiorespiratory responses following isoproterenol injection in rabbits. J Appl Physiol Respir Environ Exerc Physiol. 1979 Aug;47(2):352–359. doi: 10.1152/jappl.1979.47.2.352. [DOI] [PubMed] [Google Scholar]
  26. Zwillich C. W., Sahn S. A., Weil J. V. Effects of hypermetabolism on ventilation and chemosensitivity. J Clin Invest. 1977 Oct;60(4):900–906. doi: 10.1172/JCI108844. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES